Sponsor Pipeline

Shenzhen MagicRNA Biotechnology Co., Ltd Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
1
Recruiting
4
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-13 NCT07556120
Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG)
date change Completion pushed: 2027-12-31 -> 2028-12-31
Active Trials by Phase
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06801119 Efficacy and Safety of HN2301 in Autoimmune Diseases(AIDs) Systemic Lupus Erythematosus Recruiting
NCT07523282 Safety and Preliminary Efficacy of HN2302 in Patients With Autoimmune Diseases Autoimmune Disease Not Yet Recruiting
NCT07556120 Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia Gravis (MG) Generalized Myasthenia Gravis Not Yet Recruiting
Disease Areas
Get alerts when Shenzhen MagicRNA Biotechnology Co., Ltd's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free